학술논문

Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer
Document Type
Journal
Source
CLINICAL CANCER RESEARCH; OCT 1 2019, 25 19, p5818-p5831, 14p.
Subject
Language
English
ISSN
15573265